GL1X · GenesisL1 explorer

Research workbench

The crystal structure of the I38T mutant pa endonuclease (2009/H1N1/CALIFORNIA) in complex with SJ000988558

Analyse The crystal structure of the I38T mutant pa endonuclease (2009/H1N1/CALIFORNIA)… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
7KNR
Type
protein
Length
179 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Protein pa-X
UniProt
A0A4D6EED0, C6H0Y9
Ligands
WTD, QQ4, MN, SO4
Pockets
1 · best druggability 0.62

Structure

x-ray diffraction · 1 distinct chain · 54% helix, 13% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AProtein pa-Xprotein17954% helix, 13% strandA0A4D6EED0, C6H0Y9

Ligands and binding sites

  • WTD · 2-(2,6-difluorophenyl)-5-hydroxy-N-[2-(4-hydroxy-3-methoxyphenyl)ethyl]-6-oxo-3,6-dihydropyrimidine-4-carboxamide · ligand · chains A
  • QQ4 · Hexa Vinylpyrrolidone K15 · ligand · chains A
  • MN · Manganese (II) ion · metal · 2 copies · chains A
  • SO4 · Sulfate ion · ion · 3 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14160.620.7737MN, WTD

Compared structures

  • 7KNR · The crystal structure of the I38T mutant PA endonuclease (2009/H1N1/California) in… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.